Identifying better biomarkers for predicting and detecting colon and esophageal cancers
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
This study is working on finding better ways to spot colorectal and esophageal cancers early, especially for people who might be at higher risk, so that doctors can help keep you healthy with the right screenings and check-ups.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10884386 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection and risk prediction of colorectal and esophageal cancers, which are significant causes of cancer-related deaths in the U.S. The project aims to develop better biomarkers that can help distinguish between high-risk and low-risk individuals for these cancers, thereby optimizing screening and surveillance strategies. By identifying individuals at higher risk due to factors like family history or precancerous conditions, the research seeks to enhance the effectiveness of current screening methods and reduce the incidence of preventable cancers. Patients may be monitored more accurately based on their risk levels, leading to timely interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of colorectal cancer, those with hereditary cancer syndromes, or patients diagnosed with Barrett's esophagus.
Not a fit: Patients without any risk factors for colorectal or esophageal cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer screenings and ultimately reduce the mortality rates associated with colorectal and esophageal cancers.
How similar studies have performed: Previous research has shown promise in developing biomarkers for cancer detection, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Grady, William Mallory — Fred Hutchinson Cancer Center
- Study coordinator: Grady, William Mallory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.